INTERCURE Revenue and Competitors
Estimated Revenue & Valuation
- INTERCURE's estimated annual revenue is currently $4.6M per year.
- INTERCURE's estimated revenue per employee is $201,000
Employee Data
- INTERCURE has 23 Employees.
- INTERCURE grew their employee count by -15% last year.
INTERCURE's People
| Name | Title | Email/Phone |
|---|
INTERCURE Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $8.8M | 44 | 0% | $22.5M | N/A |
#2 | $4.6M | 23 | -15% | N/A | N/A |
What Is INTERCURE?
InterCure (dba Canndoc) (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) is the leading, profitable, and fastest growing cannabis company outside of North America. Canndoc, a wholly owned subsidiary of InterCure, is Israel’s largest licensed cannabis producer and one of the first to offer Good Manufacturing Practices (GMP) certified and pharmaceutical-grade medical cannabis products. InterCure leverages its market leading distribution network, best in class international partnerships and a high-margin vertically integrated \seed-to-sale\ model to lead the fastest growing cannabis global market outside of North America.\n\nFor more information, visit: http://www.intercure.co.
keywords:N/A
N/A
Total Funding
23
Number of Employees
$4.6M
Revenue (est)
-15%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in Herzliya
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $3.2M | 23 | 5% | N/A |
#2 | $2.3M | 23 | N/A | N/A |
#3 | $3.1M | 28 | 155% | N/A |
#4 | $5.3M | 28 | 0% | N/A |
#5 | $5.6M | 30 | 50% | N/A |